Cargando…

237P Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: A joint analysis of OnCovid and ESMO-CoCARE registries

Detalles Bibliográficos
Autores principales: Cortellini, A., Dettorre, G., Dafni, U., Aguilar Company, J., Castelo-Branco, L., Lambertini, M., Gennatas, S., Rogado, J., Vinal Lozano, D., Harrington, K.J., Tsourti, Z., Michielin, O.A., Pommeret, F., Brunet Vidal, J.M., Tabernero, J., Pentheroudakis, G., Gennari, A., Peters, S., Romano, E., Pinato, D.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732918/
http://dx.doi.org/10.1016/j.iotech.2022.100226
_version_ 1784846238015815680
author Cortellini, A.
Dettorre, G.
Dafni, U.
Aguilar Company, J.
Castelo-Branco, L.
Lambertini, M.
Gennatas, S.
Rogado, J.
Vinal Lozano, D.
Harrington, K.J.
Tsourti, Z.
Michielin, O.A.
Pommeret, F.
Brunet Vidal, J.M.
Tabernero, J.
Pentheroudakis, G.
Gennari, A.
Peters, S.
Romano, E.
Pinato, D.J.
author_facet Cortellini, A.
Dettorre, G.
Dafni, U.
Aguilar Company, J.
Castelo-Branco, L.
Lambertini, M.
Gennatas, S.
Rogado, J.
Vinal Lozano, D.
Harrington, K.J.
Tsourti, Z.
Michielin, O.A.
Pommeret, F.
Brunet Vidal, J.M.
Tabernero, J.
Pentheroudakis, G.
Gennari, A.
Peters, S.
Romano, E.
Pinato, D.J.
author_sort Cortellini, A.
collection PubMed
description
format Online
Article
Text
id pubmed-9732918
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Society for Medical Oncology. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-97329182022-12-09 237P Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: A joint analysis of OnCovid and ESMO-CoCARE registries Cortellini, A. Dettorre, G. Dafni, U. Aguilar Company, J. Castelo-Branco, L. Lambertini, M. Gennatas, S. Rogado, J. Vinal Lozano, D. Harrington, K.J. Tsourti, Z. Michielin, O.A. Pommeret, F. Brunet Vidal, J.M. Tabernero, J. Pentheroudakis, G. Gennari, A. Peters, S. Romano, E. Pinato, D.J. Immunooncol Technol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2022-12 2022-12-09 /pmc/articles/PMC9732918/ http://dx.doi.org/10.1016/j.iotech.2022.100226 Text en Copyright © 2022 European Society for Medical Oncology. Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Cortellini, A.
Dettorre, G.
Dafni, U.
Aguilar Company, J.
Castelo-Branco, L.
Lambertini, M.
Gennatas, S.
Rogado, J.
Vinal Lozano, D.
Harrington, K.J.
Tsourti, Z.
Michielin, O.A.
Pommeret, F.
Brunet Vidal, J.M.
Tabernero, J.
Pentheroudakis, G.
Gennari, A.
Peters, S.
Romano, E.
Pinato, D.J.
237P Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: A joint analysis of OnCovid and ESMO-CoCARE registries
title 237P Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: A joint analysis of OnCovid and ESMO-CoCARE registries
title_full 237P Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: A joint analysis of OnCovid and ESMO-CoCARE registries
title_fullStr 237P Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: A joint analysis of OnCovid and ESMO-CoCARE registries
title_full_unstemmed 237P Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: A joint analysis of OnCovid and ESMO-CoCARE registries
title_short 237P Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: A joint analysis of OnCovid and ESMO-CoCARE registries
title_sort 237p immune checkpoint inhibitor therapy and outcomes from sars-cov-2 infection in patients with cancer: a joint analysis of oncovid and esmo-cocare registries
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732918/
http://dx.doi.org/10.1016/j.iotech.2022.100226
work_keys_str_mv AT cortellinia 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries
AT dettorreg 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries
AT dafniu 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries
AT aguilarcompanyj 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries
AT castelobrancol 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries
AT lambertinim 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries
AT gennatass 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries
AT rogadoj 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries
AT vinallozanod 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries
AT harringtonkj 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries
AT tsourtiz 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries
AT michielinoa 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries
AT pommeretf 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries
AT brunetvidaljm 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries
AT taberneroj 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries
AT pentheroudakisg 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries
AT gennaria 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries
AT peterss 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries
AT romanoe 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries
AT pinatodj 237pimmunecheckpointinhibitortherapyandoutcomesfromsarscov2infectioninpatientswithcancerajointanalysisofoncovidandesmococareregistries